COPD inhaler showdown: which triple therapy wins?
NCT ID NCT06905483
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared two different triple-combination inhalers (BGF and FUV) in 22 people with stable COPD. The goal was to see which one better improves small airway function. Participants used each inhaler for a period and then switched, allowing a direct comparison of their effects on lung tests and safety.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Narongkorn Saiphoklang
Pathum Thani, Changwat Pathum Thani, 12120, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test may curb antibiotic overuse in COPD attacks
- Can pressurized breathing boost mucus clearance in lung disease?
- HIV and hidden health risks: a major study probes the link
- New inhaled compound aims to ease COPD breathing woes
- Ultrasound might reveal hidden lung damage in COPD
- Can tracking early COPD reveal ways to halt its progression?